Table: OncoTherapy Science -2024/25 group results

OncoTherapy Science

09/05/2025 09:00

May 9 (Reuters)- 
          OncoTherapy Science Inc 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2025    Mar 31, 2024   Mar 31, 2026     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales          750 mln         610 mln                               
               (+22.9 pct)     (-46.2 pct)                             
  Operating   loss 797 mln      loss 1.12                              
  Recurring   loss 815 mln      loss 1.14                              
  Net
  Net         loss 815 mln      loss 1.29                              
  EPS         loss 3.12 yen   loss 6.05 yen                            
  Ann Div          NIL             NIL            NIL                  
  -Q2 Div
  -Q4 Div          NIL             NIL            NIL                  
  
  NOTE - OncoTherapy Science Inc.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4564.T